Big pharma blockbuster obesity drug battle is headed for $100 billion
Ozempic drug to treat diabetes.Courtesy: OzempicOf their most up-to-date earnings reports, Novo Nordisk and Eli Lilly proved why they're the ...
Ozempic drug to treat diabetes.Courtesy: OzempicOf their most up-to-date earnings reports, Novo Nordisk and Eli Lilly proved why they're the ...
Robert Galbraith | ReutersThe Federal Trade Commission last week allowed Amgen to maneuver forward with its $27.8 billion acquisition of ...
Liselotte Sabroe | Afp | Getty ImagesNovo Nordisk on Thursday said it should acquire Inversago Pharma, a privately held obesity ...
A whole bunch of 1199SEIU health care employees staged a rally and sit to dam third avenue where some were ...
It is time for investors to get back into British pharmaceutical company GSK , in response to investor Sarat Sethi. ...
WASHINGTON (Reuters) -U.S. regulators asked a federal judge on Friday to carry Martin Shkreli in contempt for allegedly impeding its ...
Investors on the lookout for cover this 12 months would have done well in the event that they sought a ...
In a wide-ranging conversation with Scott Pelley, President Biden answers questions on Taiwan, inflation, the classified documents found in former ...
[mailpoet_form id=”1″]
© 2022. All Right Reserved By Inbvnews.com